Product Description
Lanluma V is an absorbable injectable based on poly-L-Lactic that gradually restores volume and stimulates collagen formation. The results appear over two to three months. Lanluma can be used for both body and face and activates the natural collagen production in the skin. The filler is perfect for medium to deep facial lines in the area of cheeks, chin, jawline, temples, and nasolabial folds. The filler is also very useful in areas of scarring.
The pack consists of:
Vial 1 x 15 ml
AesPlla® is a Poly-L-Lactic Acid-based (PLLA) filler and collagen stimulator. Formulated with a biocompatible and biodegradable synthetic polymer, the injectable stimulates collagen production to help volumise and smooth. Offering gradual results, the bio-stimulatory treatment works to correct the appearance of shallow to deep nasolabial fold contour deficiencies and facial wrinkles. Subsequent results may be observed from four weeks post-treatment, lasting up to 3 years.
How is aesPLLA ® prepared?
The aesPLLA ® should be mixed with 5 ml of sterile, distilled water and 2 ml of lido caine and at least 0.5 to 2 hours before injection. For the exact preparation and use of this product, please refer to the attached protocol.
How quickly are the results visible with aesPLLA ®?
The achieved effect of the aesPLLA ® is usually visible and noticeable after about 4 to 6 weeks after the treatment.
How often should aesPLLA ® be applied?
To achieve satisfactory results, it is advisable to use this product mesotherapeutically and in about 2 to 3 sessions.
Approximately how long do the aesPLLA ® results last?
The results of this product can last for about 1 to 2 years, depending on the condition of the client's skin.
Under which layer of skin and using which cannula should aesPLLA ® be injected?
In general, aesPLLA ® should be injected into the subcutaneous dermis using a 21G or 23G needle. The punctured fan technique is also recommended, which produces the best possible and therefore satisfactory results
What dose should be applied to each treatment area of the aesPLLA ®?
Depending on the treatment area, the injection dose of this product to be used differs. Thus, approximately 2 to 3 ml should be used on each temple, 1 to 1.5 ml on each lacrimal sac and 2 to 2.5 ml on each cheek. It is further recommended that a dose of 2 to 2.5 ml be applied to one nasolabial fold at a time, 1 to 1.5 ml to each marionette fold and approximately 6 ml to rather larger areas of the face.
Audited Supplier 
){kind=link}
){kind=link}